Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Interest Coverage Ratio of 5.06 for Q1 2026, up 507.32% year-over-year from 0.83 in Q1 2025, and up 34.68% quarter-over-quarter from 3.75 in Q4 2025.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 5.06 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 507.32% year-over-year to 5.06; the TTM figure through Mar 2026 stood at 52.99 (up 1750.91% YoY), while the FY2025 annual figure was 2.69, up 3556.46% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 5.06, up from 3.75 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 6.34 in Q4 2024, with the low at 8.06 in Q1 2023.
- The 5-year median for Interest Coverage Ratio is 0.03 (2024), against an average of 0.07.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio sank 268.43% in 2022, then surged 15662.99% in 2025.
- Rigel Pharmaceuticals' Interest Coverage Ratio stood at 0.5 in 2022, then soared by 245.05% to 0.73 in 2023, then soared by 772.64% to 6.34 in 2024, then plunged by 40.82% to 3.75 in 2025, then soared by 34.68% to 5.06 in 2026.
- Business Quant data shows RIGL's Interest Coverage Ratio at 5.06 in Q1 2026, 3.75 in Q4 2025, and 1.85 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Rigel Pharmaceuticals | 901.09 Mn | 805.76 Mn | 70.18 Mn | 30.26 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.26 |
| Mar 31, 2026 | 8.29 |
| Dec 31, 2025 | 13.64 |
| Sep 30, 2025 | 15.01 |
| Jun 30, 2025 | 32.61 |
| Mar 31, 2025 | 6.89 |
| Dec 31, 2024 | 8.52 |
| Sep 30, 2024 | 6.82 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | -3.72 |
| Dec 31, 2023 | 1.03 |
| Sep 30, 2023 | -2.35 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | -10.57 |
| Dec 31, 2022 | 1.88 |
| Sep 30, 2022 | -22.28 |
| Jun 30, 2022 | -22.79 |
| Mar 31, 2022 | -21.79 |
| Dec 31, 2021 | -16.49 |
| Sep 30, 2021 | -15.02 |